Company takes minority stake in animal health’s most advanced microbiome biotech company.

February 20, 2023

1 Min Read
cattle feedlot feed bunk FDS.jpeg
Getty Images

Nutreco, global leader in animal nutrition and aquafeed, has taken a minority stake in animal health’s most advanced microbiome biotech company, BiomEdit. The two companies recently entered into a ground-breaking, long-term strategic research and commercial partnership – the first since BiomEdit was founded – to bring livestock and aquaculture producers innovative and truly novel feed additives developed through microbiome technology. The announcement represents a further strengthening of this partnership.

“Through this investment, we are reinforcing the unique collaboration that brings together BiomEdit’s state-of-the-art microbiome discovery platform and Nutreco’s customer access and distribution capabilities,” said Fulco van Lede, chief executive officer of Nutreco. “We’re excited about its potential to help us super-charge our supply of proprietary ultra-specialty ingredients, speed up progress on our purpose of Feeding the Future and create a more sustainable future for our industry.”

Aaron Schacht, CEO of BiomEdit, commented, “Nutreco's investment in BiomEdit underscores our strategic partnership and a shared mission to create novel animal health solutions through the untapped potential of the microbiome. We are pleased that Nutreco, a global leader in animal nutrition and aquafeed, is joining our roster of world-class Series A investors to help fuel innovation in feed additive products."

Nutreco took the minority stake in BiomEdit through the company’s recent Series A financing round, initially raised in April 2022 in its carve-out from Elanco Animal Health including contributions of assets and technology from Ginkgo Bioworks and Elanco. Anterra Capital, Viking Global Investors and Ferment are also investors in BiomEdit.

Subscribe to Our Newsletters
Feedstuffs is the news source for animal agriculture

You May Also Like